Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amazon
AMZN
$2.5T
| $1.24B | 0.38% |
57,139,980
+1,035,900
| +2% | +$21.7M |
|
|
27
Qualcomm
QCOM
$176B
| $1.24B | 0.38% |
19,754,722
+8,608,498
| +77% | +$587M |
|
28
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
| $1.22B | 0.38% |
30,732,600
-5,573,900
| -15% | -$233M |
|
29
Viatris
VTRS
$20.1B
| $1.2B | 0.37% |
17,723,442
-1,990,067
| -10% | -$141M |
|
|
30
Gilead Sciences
GILD
$161B
| $1.15B | 0.36% |
9,824,048
-9,739,392
| -50% | -$1.06B |
|
31
State Street SPDR S&P Bank ETF
KBE
$1.64B
| $1.12B | 0.35% |
30,855,852
-37,963
| -0.1% | -$1.33M |
|
32
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $1.12B | 0.35% |
15,023,365
-2,129,295
| -12% | -$158M |
|
33
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $1.1B | 0.34% |
13,097,169
+2,262,723
| +21% | +$176M |
|
34
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.44B
| $1.08B | 0.33% |
39,418,232
+455,326
| +1% | +$12.9M |
|
35
Enterprise Products Partners
EPD
$83.8B
| $1.06B | 0.33% |
35,496,663
+796,162
| +2% | +$26.1M |
|
36
Energy Transfer Partners
ET
$70.1B
| $1.04B | 0.32% |
32,462,506
+404,530
| +1% | +$13.6M |
|
37
Exelon
EXC
$48.6B
| $1.03B | 0.32% |
45,795,113
+1,679,086
| +4% | +$40.2M |
|
38
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
| $979M | 0.3% |
31,785,340
-800,444
| -2% | -$26.1M |
|
39
iShares Biotechnology ETF
IBB
$9.31B
| $968M | 0.3% |
7,867,914
-895,356
| -10% | -$107M |
|
|
EMC
40
DELISTED
EMC CORPORATION
EMC
| $957M | 0.3% |
36,258,248
-3,168,137
| -8% | -$84.5M |
|
|
41
iShares MSCI Emerging Markets ETF
EEM
$28B
| $943M | 0.29% |
23,802,413
+3,630,827
| +18% | +$152M |
|
42
Abbott
ABT
$180B
| $894M | 0.28% |
18,215,388
+2,253,134
| +14% | +$108M |
|
|
43
CALL
iShares Russell 2000 ETF
IWM
$80.9B
| $891M | 0.28% |
7,136,200
+1,583,400
| +29% | +$198M |
|
44
Invesco QQQ Trust
QQQ
$455B
| $883M | 0.27% |
8,247,339
+1,452,524
| +21% | +$158M |
|
45
Citigroup
C
$222B
| $873M | 0.27% |
15,799,101
-3,067,996
| -16% | -$167M |
|
46
American Tower
AMT
$77.7B
| $860M | 0.27% |
9,221,766
-482,061
| -5% | -$45.6M |
|
47
Visa
V
$677B
| $847M | 0.26% |
12,612,884
-3,908,446
| -24% | -$265M |
|
|
48
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
| $847M | 0.26% |
21,375,400
-1,230,300
| -5% | -$51.5M |
|
49
Verizon
VZ
$194B
| $846M | 0.26% |
18,152,991
-562,922
| -3% | -$27.6M |
|
50
Wells Fargo
WFC
$261B
| $845M | 0.26% |
15,022,668
-1,316,542
| -8% | -$73.4M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.